BioPharmX (BPMX) Tops Q1 EPS by 1c
June 14, 2016 4:15 PM
BioPharmX (NYSE: BPMX) reported Q1 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17).
Cash and cash equivalents as of April 30, 2016, were $4.0 million.
(0)
(0)
BioPharmX Corporation (BPMX) Stock Research Links
-
-
-
-
-
-
-
